The evolution of anemic syndrome against the background of chronic kidney disease in real clinical practice


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Objective. Assessment of the individual characteristics of patients with chronic kidney dis-ease (CKD) with the presence of anemic syndrome (As) at various stages of medical care in real clinical practice. Materials and methods. The study included 762 CKD patients who were admitted to the endocrinological, nephrology and dialysis departments, and the results of the examination of which revealed anemia of varying severity. Criteria for inclusion in the study corresponded to modern generally accepted classification categories. Results. In patients with kidney damage, AS was detected already at the stage of non-specialized (endocrinological) department, with a regular increase in the proportion of this cohort of patients and the severity of the condition in the specialized nephrology department, and in the settings of the dialysis department. Gender and age analysis of patients showed that anemia is most often detected in women of older age, which requires tight control of red blood cell parameters in order to timely start antianemic therapy for the improvement of the prognosis of patients. The most "favorable" background for the development of anemia in CKD includes glomerulonephritis, often leading to the most rapid progression of renal failure and direct disruption of the erythropoietin production. Conclusion. In order to improve the prognosis of CKD patients with anemic syndrome, early intervention into pathological process at the stage of non-specialized department is necessary, with close adherence to the principles of continuity of medical care.

Full Text

Restricted Access

About the authors

S. I Korneeva

Kursk State Medical University of the Ministry of Health of the Russian Federation

Email: snezhanakorneeva@mail.ru
Teaching Assistant at the Department of Internal Diseases Kursk, Russia

S. A Pribylov

Kursk State Medical University of the Ministry of Health of the Russian Federation; Kursk Regional Clinical Hospital

Deputy Chief Physician for Treatment; Head of the Department of Internal Diseases Kursk, Russia

A. V Bezgin

Kursk State Medical University of the Ministry of Health of the Russian Federation; Kursk Regional Clinical Hospital

Professor at the Department of Internal Diseases № 1 Kursk, Russia

A. Trigub

Kursk State Medical University of the Ministry of Health of the Russian Federation

Resident Medical Practitioner at the Department of Internal Diseases Kursk, Russia

References

  1. Бикбов Б.Т., Томилина Н.А. Заместительная терапия терминальной хронической почечной недостаточности в Российской Федерации в 1998- 2013 гг. Отчет по данным Российского регистра заместительной почечной терапии. Часть I. Нефрология и диализ. 2015; 17(3): 6-11
  2. Герасимова О.Ю., Семченко Л.Н., Ременец С.С. Эпидемиология хронических болезней почек и организация медицинской помощи больным при хронической почечной недостаточности (обзор литературы). Южно-Уральский медицинский журнал. 2016; 4: 4-9.
  3. Chronic kidney disease: global dimension and perspectives. Lancet. 2013; 382(9888): 260-272. doi: 10.1016/S0140-6736(13)60687-X.
  4. Драчев И.Ю., Шило В.Ю. Хроническая болезнь почек и заместительная почечная терапия: медико-социальные и клинические аспекты проблемы (обзор литературы). Верхневолжский медицинский журнал. 2016; 15(4): 45-49.
  5. Matsushita K., van der Velde M., Astor B.C., et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet. 2010; 375: 2073-2081.
  6. Климов А.В., Денисов Е.Н., Иванова О.В. Артериальная гипертензия и ее распространенность среди населения. Молодой ученый. 2018; 50: 86-90.
  7. Хантакова Е.А. Анемический синдром у больных сахарным диабетом 1 типа при диабетической нефропатии. Сибирский медицинский журнал. 2013; 4: 51-54.
  8. Park H., Liu X., Henry L., et al. Trends in anemia care in non-dialysis-dependent chronic kidney disease (CKD) patients in the United States (2006-2015). BMC Nephrology. 2018; 19(318): 1-15. doi: 10.1186/s12882-018-1119-7.
  9. Гусева В.М. Анемия у пациентов старческого возраста с хронической болезнью почек. Уральский медицинский журнал 2013; 1(106): 131-135.
  10. Мартынов С.А., Шестакова М.В., Шилов Е.М. и др. Распространенность анемии у больных сахарным диабетом 1 и 2 типа с поражением почек. Сахарный диабет. 2017; 20(5): 318-328.
  11. Лагонская В.Н. Влияние анемии на биохимические показатели при заболеваниях печени и почек. Медицинский альманах. 2011; 6(19): 269-272.
  12. Шилов Е.М., Добронравов В.А., Земченков А.Ю. и др. Российские национальные рекомендации по диагностике и лечению анемии при хронической болезни почек. Нефрология и диализ. 2016; 1: 19-34.

Supplementary files

Supplementary Files
Action
1. JATS XML

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies